Journal Article (Letter)

DKFZ-2026-02490

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Impact of immunocompromised status on real-world outcomes with avelumab treatment in advanced Merkel cell carcinoma: findings from the prospective MCC-TRIM registry.

Becker, J.DKFZ* ; Mahmoudpour, S. H. ; Schadendorf, D.DKFZ* ; Leiter, U. ; Meier, F.DKFZ* ; Herbst, R. ; Grabbe, S. ; Gebhardt, C. ; Ziller, F. ; Pföhler, C. ; Mohr, P. ; Zimmer, L.DKFZ* ; Boutmy, E. ; Oksen, D. ; Kearney, M. ; Ruth, K. ; Hoff, S. ; Shlaen, M. ; Ugurel, S.

2026
Oxford University Press Oxford

Note: #DKTKZFB26# / #NCTZFB26# / epub

---

Contributing Institute(s):

1. DKTK Koordinierungsstelle Essen/Düsseldorf (ED01)
2. Koordinierungsstelle NCT West (WT01)
3. DKTK ED Translationale Hautkrebsforschung (ED03)
4. Koordinierungsstelle NCT Dresden (DD04)

Research Program(s):

1. 899 - ohne Topic (POF4-899) (POF4-899)

Appears in the scientific report 2026

---

Database coverage:
; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Current Contents - Life Sciences ; DEAL Wiley ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 10 ; JCR ; Nationallizenz ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---